In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers

David S. Alberts, Paul T. Fanta, Kelli L. Running, Laurence P. Adair, Dava J. Garcia, Rosa Liu-Stevens, Sydney E. Salmon

Research output: Contribution to journalArticlepeer-review

55 Scopus citations

Fingerprint Dive into the research topics of 'In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds